Compare · head to head
AxoGen vs CONMED
CONMED ranks higher overall — 360 rank 44 vs 43.
CONMED leads on Value (70 vs 38) and Quality (65 vs 46). AxoGen leads on Growth (55 vs 33), Safety (48 vs 28) and Sentiment (54 vs 47).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| Size | Small | Small |
| ISIN | US05463X1063 | US2074101013 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 43 | 44 |
| Value | 38 | 70 |
| Quality | 46 | 65 |
| Growth | 55 | 33 |
| Safety | 48 | 28 |
| Sentiment | 54 | 47 |
| Quality details | ||
| Profitability | 40 | 63 |
| Cash Truth | 53 | 67 |
AxoGen vs SANUWAVE HealthAxoGen vs AtriCureAxoGen vs Integra LifeSciencesAxoGen vs Spectral AIAdd a third stock →
Full analyses: AxoGen · CONMED
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100